Zeo ScientifiX (ZEOX) EPS (Basic) Growth (1y) (2013 - 2026)
Zeo ScientifiX (ZEOX) EPS (Basic) Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 322.67% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 96.41% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -16.29% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -147.33% |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | 69.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 69.77% |
| Jan 31, 2026 | 37.07% |
| Oct 31, 2025 | 52.18% |
| Jul 31, 2025 | -71.83% |
| Apr 30, 2025 | 13.08% |
| Jan 31, 2025 | -4.63% |
| Oct 31, 2024 | -21.41% |
| Jul 31, 2024 | -16,605.69% |
| Apr 30, 2024 | -18,338.50% |
| Jan 31, 2024 | -11,674.83% |
| Oct 31, 2023 | -6,986.93% |
| Jul 31, 2023 | 54.61% |
| Apr 30, 2023 | -3.02% |
| Jan 31, 2023 | -2.01% |
| Oct 31, 2022 | -193.47% |
| Jul 31, 2022 | -96.28% |
| Apr 30, 2022 | 36.49% |
| Jan 31, 2022 | 81.04% |
| Oct 31, 2021 | 88.25% |
| Jul 31, 2021 | 82.13% |